Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Aerosolized immunogenic compositions that may prove useful for vaccination against respiratory infections and may provide a platform for generating mucosal antibody responses against other pathogens. More
Related Reports
Market Research Reports provided by reports.innovaro.com
Jun 2008 - 175 pages - $3,835
Oct 2011 - 92 pages - $3,835
Apr 2007 - 475 pages - $6,995
Jan 2011 - 124 pages - $1,740
Feb 2011 - 5 pages - $500
Jun 2009 - 118 pages - $1,040
Nov 2009 - 830 pages - $1,040
Dec 2010 - 35 pages - $500
Aug 2011 - 34 pages - $500
Apr 2011 - 40 pages - $500
Your selection
Browse By
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us